Thanks, Dr. Sauer.
This is going to be an important part of BioVectra's ability to face whatever the next seven-year cycle brings us in terms of a pandemic.
Are you facing any other hurdles in terms of fill and finish, or production capacity? Is there anything else that would stand between you today and being able to address whatever the next pandemic might be?